Jin-Feng Liu
Overview
Explore the profile of Jin-Feng Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
136
Citations
1081
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Qin W, Liu Y, Liu J, Zhou L, Yang S, Gu J, et al.
Microb Biotechnol
. 2025 Mar;
18(3):e70111.
PMID: 40079915
Outer space is an extreme environment and the survival of many microorganisms after spaceflight is well established. However, adaptations of Bacillus subtilis to space stress, particularly metabolism, are largely unknown....
2.
Liu J, Bai Y, Leng Y, Chang E, Wei Y, Wei W
Expert Opin Drug Saf
. 2025 Feb;
:1-8.
PMID: 39912511
Background: Luspatercept, approved for treating beta thalassemia, myelodysplastic syndromes (MDS) associated anemia, and MDS with ring sideroblasts or myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis associated anemia, has uncertain long-term...
3.
Qi G, Qin W, Li G, Ma T, Liu Y, Zhou L, et al.
Appl Biochem Biotechnol
. 2024 Oct;
197(2):1192-1208.
PMID: 39404998
A new lipopeptide-producing strain Cytobacillus sp. R3-1 was isolated from the production water of the Daqing oilfield in China and identified based on 16S rRNA gene sequence analyses. The strain...
4.
An D, Li Z, Zhao X, Liu J
World J Otorhinolaryngol Head Neck Surg
. 2024 Sep;
10(3):241-243.
PMID: 39233866
Purpose: To report a rare variant of the posterior septal artery (PSA), which supplies blood to the posterior mucosa of the contralateral nasal septum. Case Report: A 31-year-old female patient...
5.
Wang H, Liu J, Wang F, Yuan T, Jiang H, Wei Z, et al.
Medicine (Baltimore)
. 2024 Aug;
103(32):e39237.
PMID: 39121305
Background: The approach of total hip arthroplasty (THA) has long been controversial, and many studies have compared different approaches. However, there is still a lack of consistent conclusions and comprehensive,...
6.
Zhang Y, Wei W, Chang E, Leng Y, Hou Y, Wei X, et al.
J Gynecol Obstet Hum Reprod
. 2024 Aug;
53(9):102829.
PMID: 39096881
Background: Elagolix, an approved non-peptide GnRH antagonist, shows promise in relieving endometriosis-related pain, but its short- and mid-term efficacy and potential side effects are still under investigation. Objective: The aim...
7.
Wei W, Bai Y, Chang E, Liu J
Expert Opin Drug Saf
. 2024 Jul;
:1-9.
PMID: 39078338
Objective: Fostamatinib, an FDA-approved oral small-molecule spleen tyrosine kinase (SYK) inhibitor, is used to treat thrombocytopenia in adults with chronic immune thrombocytopenia (ITP) who have not responded to previous treatments....
8.
Feng Y, Liu J, Xue Y, Liu D, Wu X
Chin J Integr Med
. 2024 Jun;
30(11):984-992.
PMID: 38941043
Objective: To explore the specific pharmacological molecular mechanisms of Laoke Formula (LK) on treating advanced non-small cell lung cancer (NSCLC) based on clinical application, network pharmacology and experimental validation. Methods:...
9.
Chang E, Shi Y, Liu J, Wei W
Expert Opin Drug Saf
. 2024 May;
23(12):1545-1552.
PMID: 38700323
Objective: Elagolix is approved for the treatment of moderate-to-severe pain associated with endometriosis. However, the long-term safety of elagolix in a large sample of real-world patients is unknown. Methods: The...
10.
Liu J, Huang L, Zhou X, Li C, Liu M, Liang Y, et al.
Transl Cancer Res
. 2024 Mar;
13(2):496-514.
PMID: 38482398
Background: Understanding the interplay between disulfidptosis, ferroptosis, and hepatocellular carcinoma (HCC) could provide valuable insights into the pathogenesis of HCC and potentially identify novel therapeutic targets for the treatment of...